Ingevity (NYSE:NGVT) Shares Gap Up – Here’s Why

Posted by Brian Himes on Nov 12th, 2026

Ingevity Corporation (NYSE:NGVT – Get Free Report) gapped up before the market opened on Thursday. The stock had previously closed at $60.78, but opened at $63.01. Ingevity shares last traded at $62.9650, with a volume of 2,455 shares trading hands.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Wall Street Zen downgraded shares of Ingevity from a “buy” rating to a “hold” rating in a report on Saturday, November 7th. Weiss Ratings upgraded Ingevity from a “hold (c-)” rating to a “hold (c)” rating in a research report on Wednesday, November 4th. Two equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $80.00.

Get Our Latest Analysis on Ingevity

Ingevity Stock Down 0.3%

The stock has a market capitalization of $2.13 billion, a price-to-earnings ratio of 37.09 and a beta of 1.12. The company has a quick ratio of 1.05, a current ratio of 1.48 and a debt-to-equity ratio of 15.70. The firm has a 50-day moving average of $69.98 and a two-hundred day moving average of $71.15.

Ingevity (NYSE:NGVT – Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The company reported $1.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.56 by $0.07. The business had revenue of $305.10 million during the quarter, compared to analyst estimates of $303.91 million. Ingevity had a net margin of 5.28% and a return on equity of 405.38%. As a group, sell-side analysts anticipate that Ingevity Corporation will post 5.40 earnings per share for the current year.

Insider Buying and Selling

In other Ingevity news, CEO David Li sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $75.83, for a total value of $379,150.00. Following the transaction, the chief executive officer owned 120,636 shares in the company, valued at approximately $9,147,827.88. This represents a 3.98% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 10,092 shares of company stock worth $764,673 over the last quarter. Insiders own 0.88% of the company’s stock.

Institutional Investors Weigh In On Ingevity

Institutional investors have recently modified their holdings of the stock. Frazier Financial Advisors LLC acquired a new stake in Ingevity during the second quarter valued at $37,000. Global Retirement Partners LLC purchased a new position in Ingevity in the second quarter valued at about $45,000. Harbor Investment Advisory LLC purchased a new position in Ingevity in the second quarter valued at about $71,000. Public Employees Retirement System of Ohio acquired a new position in Ingevity in the 2nd quarter worth about $75,000. Finally, Assetmark Inc. increased its position in Ingevity by 9.6% in the 1st quarter. Assetmark Inc. now owns 1,584 shares of the company’s stock worth $113,000 after purchasing an additional 139 shares during the last quarter. Institutional investors and hedge funds own 91.59% of the company’s stock.

About Ingevity

(Get Free Report)

Ingevity is a specialty chemicals and materials company headquartered in North Charleston, South Carolina. It develops and manufactures high-performance activated carbon and specialty chemical products for industrial and consumer applications. Its activated carbon products are used in vehicle fuel-vapor emission control and other applications. The company also makes specialty chemicals and polymer materials used in areas such as pavement technologies, coatings, adhesives and elastomers. Ingevity serves customers in markets around the world.